HARVARD STUDY: SPIKE IN US DRUG PRICES STEM FROM GOV. GRANTED MONOPOLY RIGHTS
A new study by the medical school of Harvard University in Cambridge, Massachusetts has revealed that the high cost of drugs in the United States is due to the country’s government granting of monopoly to the big pharmaceutical companies manufacturing the drugs.
Read More